Web Analytics Made Easy - Statcounter
top of page
ST-001 nanoFenretinide logo

Phase 1 Clinical Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

 

ClinicalTrials.gov Identifier: NCT04234048

bottom of page